2023-03-30T16:58:22+08:00 weekly 1.0 https://my.prisysbiotech.com/ 2024-11-10T16:47:12+08:00 weekly 0.9 https://my.prisysbiotech.com/metabolic-syndromes-research 2024-11-10T17:12:44+08:00 weekly 0.9 https://my.prisysbiotech.com/ophthalmic-disease-research 2024-11-10T16:47:21+08:00 weekly 0.9 https://my.prisysbiotech.com/hematological-disease-research 2024-11-10T16:47:25+08:00 weekly 0.9 https://my.prisysbiotech.com/inflammation-immunology-disorders 2023-02-27T15:56:40+08:00 weekly 0.9 https://my.prisysbiotech.com/co-develop 2024-11-10T17:12:47+08:00 weekly 0.9 https://my.prisysbiotech.com/respiratory-disease-research 2024-11-10T16:47:20+08:00 weekly 0.9 https://my.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-10T16:46:59+08:00 weekly 0.9 https://my.prisysbiotech.com/animal-welfare 2024-11-10T16:47:00+08:00 weekly 0.9 https://my.prisysbiotech.com/translational-research-center 2024-11-10T16:46:56+08:00 weekly 0.9 https://my.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://my.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://my.prisysbiotech.com/nephrology 2024-11-10T16:47:08+08:00 weekly 0.9 https://my.prisysbiotech.com/about-us 2024-11-10T16:47:03+08:00 weekly 0.9 https://my.prisysbiotech.com/contact-us 2023-04-01T12:16:17+08:00 weekly 0.9 https://my.prisysbiotech.com/newslist-1 2024-11-10T16:47:02+08:00 weekly 0.9 https://my.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://my.prisysbiotech.com/blog/ 2023-04-01T11:47:18+08:00 weekly 1.0 https://my.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T11:47:19+08:00 weekly 0.9 https://my.prisysbiotech.com/biosafety-research/ 2023-04-01T11:47:19+08:00 weekly 0.9 https://my.prisysbiotech.com/safety-evaluation/ 2023-04-01T11:47:19+08:00 weekly 0.9 https://my.prisysbiotech.com/pk-pd-adme/ 2023-04-01T12:16:09+08:00 weekly 0.9 https://my.prisysbiotech.com/translation-research/ 2024-04-09T23:03:37+08:00 weekly 0.9 https://my.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-10T17:12:50+08:00 weekly 0.8 https://my.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-10T16:47:08+08:00 weekly 0.8 https://my.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-10T17:13:56+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-10T17:12:43+08:00 weekly 0.8 https://my.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-10T17:12:39+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-10T16:47:04+08:00 weekly 0.8 https://my.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-10T16:47:07+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-10T16:46:58+08:00 weekly 0.8 https://my.prisysbiotech.com/translation-research/nhpresources.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-10T16:47:07+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-10T16:47:05+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-10T16:47:03+08:00 weekly 0.8 https://my.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/translation-research/translational-studies.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-10T16:47:04+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-10T16:47:05+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-10T16:47:05+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-10T16:47:05+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-10T16:47:04+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-10T17:12:43+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-10T16:47:04+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-10T16:47:07+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-10T16:47:03+08:00 weekly 0.8 https://my.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-10T17:12:50+08:00 weekly 0.8 https://my.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-10T16:46:57+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-10T16:47:08+08:00 weekly 0.8 https://my.prisysbiotech.com/translation-research/clinical-imaging.html 2024-10-05T03:19:32+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-10-05T03:19:35+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-10T16:47:02+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-10-05T03:19:36+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-10-05T03:19:36+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-10-05T03:19:40+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-10-05T03:41:23+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-07T19:04:08+08:00 weekly 0.8 https://my.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-07T20:44:41+08:00 weekly 0.8 https://my.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-01T22:22:08+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-01T22:22:15+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-24T22:33:35+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-24T22:33:39+08:00 weekly 0.8 https://my.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-25T22:05:06+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-15T08:02:55+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-22T08:36:28+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-29T19:12:21+08:00 weekly 0.8 https://my.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-06T14:41:45+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T20:04:22+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T22:44:47+08:00 weekly 0.8 https://my.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-04-01T11:47:18+08:00 weekly 0.9 https://my.prisysbiotech.com/newslist-714453-1 2023-04-01T11:47:18+08:00 weekly 0.9 https://my.prisysbiotech.com/newslist-714454-1 2024-08-03T11:07:21+08:00 weekly 0.9 https://my.prisysbiotech.com/newslist-820018-1 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66141816.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/meetprisys-sot2023-66141818.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66141819.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-sot2023-66141820.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66141822.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/gene-therapy-nhp-model-66141826.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66141828.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66141829.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66141831.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66141836.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/gene-therapy-toxicology-66274874.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67579547.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/world-parkinsons-disease-day-67581519.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67581520.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67585704.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67586511.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67586512.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67589824.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67589827.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68133639.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68133640.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68133641.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68133644.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68336832.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69094995.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69094996.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69095131.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69095133.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69096036.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69096294.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309272.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309305.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309310.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309311.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69666584.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69666585.html 2023-09-14T19:39:37+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71018961.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71018962.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71018964.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71019192.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/0-71019194.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71020971.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72337784.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72337786.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72337787.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72337788.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72337789.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72717784.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73033855.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73853545.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73853546.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74251921.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74710107.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74821756.html 2024-02-21T23:47:31+08:00 weekly 0.8 https://my.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75179870.html 2024-11-10T16:46:59+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75179871.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76258752.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77117676.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77808294.html 2024-11-10T16:46:52+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77808312.html 2024-11-10T16:46:54+08:00 weekly 0.8 https://my.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79207575.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-asthma-model-79207578.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79207579.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79207589.html 2024-11-10T16:46:54+08:00 weekly 0.8 https://my.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79207594.html 2024-11-10T16:46:59+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79557571.html 2024-11-10T16:46:58+08:00 weekly 0.8 https://my.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79557572.html 2024-11-10T16:47:00+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79557573.html 2024-11-10T16:46:54+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pk-strategies-of-pdc-79571830.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79571832.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79571833.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79571834.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79571835.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79571837.html 2024-11-10T16:46:55+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79571838.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79571839.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79571840.html 2024-11-10T16:46:53+08:00 weekly 0.8 https://my.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79571841.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79571842.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79571843.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79571844.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79571846.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79571847.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79571848.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79571849.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79571850.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79571851.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79571852.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79571853.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79571854.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79571855.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79571856.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79571857.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79571858.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79571859.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79571860.html 2024-11-10T16:46:57+08:00 weekly 0.8 https://my.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79571861.html 2024-11-10T16:46:54+08:00 weekly 0.8 https://my.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79571862.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79571863.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79571864.html 2024-11-10T16:46:56+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79571865.html 2024-11-10T16:46:53+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79571866.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79571867.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79571869.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79571870.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79571871.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79571872.html 2024-11-10T16:46:53+08:00 weekly 0.8 https://my.prisysbiotech.com/news/mrna-based-therapies-past-79571873.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79571874.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/significance-principles-and-requirements-of-79571875.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79571876.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79571877.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79571878.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79571879.html 2024-08-04T00:05:25+08:00 weekly 0.8 https://my.prisysbiotech.com/news/mrna-based-therapies-present-79572003.html 2024-08-07T08:44:41+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656499.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81322284.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81322285.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/animal-models-of-human-diseases-81322286.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/china-experimental-monkey-industry-81322287.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81322288.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/human-disease-animal-models-81322289.html 2024-11-10T16:47:07+08:00 weekly 0.8 https://my.prisysbiotech.com/news/convection-enhanced-delivery-81322290.html 2024-11-10T17:12:48+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81322291.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81322292.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81322294.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81322297.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/compartment-pk-model-81322299.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81322341.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82303834.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82744592.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82744593.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82744594.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82744595.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82744596.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82744597.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82744599.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82744605.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82745078.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83024819.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83027899.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83030441.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83987466.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83987467.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83987468.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83987469.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83987470.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83987497.html 2025-01-18T14:55:51+08:00 weekly 0.8 https://my.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83987513.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83987525.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83987539.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243472716358656.html 2025-02-26T22:44:29+08:00 weekly 0.8 https://my.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243472895042560.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295430795125760.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295430806332416.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295430808134656.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/membranous-nephropathy-model-17295430871049216.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/animal-models-for-womens-health-17295430909174784.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295430926984192.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295431016326144.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295431020258304.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295431124984832.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295431154918400.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295431186408448.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295431211836416.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295431312090112.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295455961392128.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295456081093632.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295456176972800.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295491334759424.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298876811666432.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374215395025920.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374215458825216.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374215465526272.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374215566926848.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374215574053888.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374215601185792.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374215612703744.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374215614211072.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374215634953216.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374215709860864.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374215744660480.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374216088019968.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17456818019722240.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17456818024817664.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17456818065466368.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17456818191131648.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17456818198602752.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17456818388231168.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17456818412545024.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17456818434319360.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/key-considerations-for-dosing-volume-17456818509308928.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17456818791310336.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17456853184717824.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17456853545755648.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17502044411143168.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-copd-model-17502044430476288.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17502044568527872.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17502044569592832.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17502044613698560.html 2025-08-25T22:05:00+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17502063477646336.html 2025-09-15T08:03:07+08:00 weekly 0.8 https://my.prisysbiotech.com/news/brain-targeted-drug-delivery-17530974149387264.html 2025-09-15T08:03:14+08:00 weekly 0.8 https://my.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530974214726656.html 2025-09-15T08:03:04+08:00 weekly 0.8 https://my.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530974216283136.html 2025-09-15T08:03:12+08:00 weekly 0.8 https://my.prisysbiotech.com/news/the-importance-of-administration-volume-17530974248395776.html 2025-09-15T08:03:13+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530974275527680.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530974296056832.html 2025-09-15T08:03:14+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530974368326656.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540929767285760.html 2025-10-06T14:42:06+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17561088979674112.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17646740012753920.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17646740034282496.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17646740037297152.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17646740037952512.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17646740078273536.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17646740110533632.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17646740162995200.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/rfp-template-for-nhp-studies-17646740177855488.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17646740198302720.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-renal-biopsy-17646740389651456.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17646783569536000.html 2025-12-25T20:04:15+08:00 weekly 0.8 https://my.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674657137812480.html 2025-12-25T20:04:28+08:00 weekly 0.8 https://my.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674657182114816.html 2025-12-25T20:04:36+08:00 weekly 0.8 https://my.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674657201349632.html 2025-12-25T20:04:29+08:00 weekly 0.8 https://my.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674657205691392.html 2025-12-25T20:04:22+08:00 weekly 0.8 https://my.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674657246782464.html 2025-12-25T20:04:31+08:00 weekly 0.8 https://my.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674657293313024.html 2025-12-25T20:04:22+08:00 weekly 0.8 https://my.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674657300145152.html 2025-12-25T20:04:43+08:00 weekly 0.8 https://my.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674657305109504.html 2025-12-25T20:04:28+08:00 weekly 0.8 https://my.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674657436918784.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724373124473856.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724373140382720.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724373154210816.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724373158732800.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724373162959872.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724373197825024.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724373221958656.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724373231133696.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724373316346880.html 2026-04-30T20:39:40+08:00 weekly 0.8 https://my.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724373342839808.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://my.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://my.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://my.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://my.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://my.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://my.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html 2026-04-24T07:01:49+08:00 weekly 0.8 https://my.prisysbiotech.com/blog/pk-pd-clinical-implications-3748810.html